Form D — Cadrenal Therapeutics, Inc.
0001213900-25-127129 · filed 2025-12-31
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,396,329
- Total sold
- $4,396,329
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cadrenal Therapeutics, Inc.
- CIK
- 1937993
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 822 A1A NORTH, SUITE 306
PONTE VEDRA, FL 32082 - Phone
- (904) 300-0701
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
QUANG X. PHAM · Executive OfficerPONTE VEDRA, FL Find on LinkedIn ↗
-
MATTHEW K. SZOT · Executive OfficerPONTE VEDRA, FL Find on LinkedIn ↗
-
JEFFREY COLE · Executive OfficerPONTE VEDRA, FL Find on LinkedIn ↗
-
JAMES J. FERGUSON · Executive OfficerPONTE VEDRA, FL Find on LinkedIn ↗
-
STEVEN ZELENKOFSKE · DirectorPONTE VEDRA, FL Find on LinkedIn ↗
-
GLYNN WILSON · DirectorPONTE VEDRA, FL Find on LinkedIn ↗
-
JOHN R. MURPHY · DirectorPONTE VEDRA, FL Find on LinkedIn ↗
-
LEE S. GOLDEN · DirectorPONTE VEDRA, FL Find on LinkedIn ↗
View original on SEC EDGAR.